Targeting 12-Lipoxygenase as a Potential Novel Antiplatelet Therapy.

Tourdot BE, Holinstat M. Targeting 12-Lipoxygenase as a Potential Novel Antiplatelet Therapy. Trends Pharmacol Sci. 2017 11; 38(11):1006-1015.

View in: PubMed